EpiQuil
Dissolving microneedle patches for controlled transdermal drug delivery
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
EpiQuil is an Australian medtech company developing an investigational dissolving microneedle patch platform for controlled transdermal delivery of lipophilic active ingredients. It is one of 16 startups in UNSW Founders' 2026 10x Accelerator cohort, which each received a A$100,000 pre-seed investment.
- Website
- epiquil.com
- Stage
- pre-seed
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepageepiquil.com
For agents
Nothing listed yet.